Results 111 to 120 of about 48,162 (201)
Linked CSF reduction of phosphorylated tau and IL-8 in HIV associated neurocognitive disorder. [PDF]
, 2019 HIV-associated neurocognitive disorder (HAND) is a common condition in both developed and developing nations, but its cause is largely unknown. Previous research has inconsistently linked Alzheimer's disease (AD), viral burden, and inflammation to the ...
Anderson, Albert M +9 more
core +1 more source
Drugs in R & D, 2003 VaxGen is developing prophylactic vaccines against HIV-1 consisting of two recombinant gp120 surface proteins from different HIV-1 strains.This profile has been selected from R&D Insight, a pharmaceutical intelligence database produced by Adis International Ltd.
openaire +2 more sources
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. [PDF]
, 2019 Broadly neutralizing monoclonal antibodies protect against infection with HIV-1 in animal models, suggesting that a vaccine that elicits these antibodies would be protective in humans.
Abernathy, Morgan E +31 more
core
MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-ASSOCIATED VACCINE PROTECTION FROM SIMIAN IMMUNODEFICIENCY VIRUS-INFECTED PERIPHERAL-BLOOD CELLS [PDF]
, 1994 Boes, J +14 more
core +1 more source
Antiretroviral effect of 4-thio-uridylate against human immunodeficiency virus type 1 [PDF]
, 2012 Albert J. +32 more
core +1 more source
LncRNA SNHG1 Knockdown Ameliorates HIV-1 gp120V3 Loop-Induced Microglial Neuroinflammation by Regulating the Autophagy Process. [PDF]
InflammationYan X +12 more
europepmc +1 more source